Table 1.
Characteristics of Patients Analyzed at Baseline, 6 Months, and 12 Months of Starting Antiretroviral Therapy
| Parameter | Baseline (n=130) | Follow-up at 6 months (n=109) | Follow-up at 12 months (n=88) |
|---|---|---|---|
| Age group (years) | |||
| <40 | 84 | 70 | 54 |
| ≥40 | 46 | 39 | 34 |
| Gender | |||
| Male | 86 | 74 | 59 |
| Female | 44 | 35 | 29 |
| Clinical staging | |||
| I | 63 | 101 | 77 |
| II | 34 | 6 | 3 |
| III | 29 | 2 | 2 |
| IV | 4 | 0 | 6 |
| CD4 counts (cells/μl) | |||
| <50 | 19 | 4 | 1 |
| 50–199 | 90 | 47 | 30 |
| ≥200 | 21 | 58 | 57 |
| HIV viral load (copies/ml) | |||
| <50 | 5 | 37 | 60 |
| 50–1,000 | 2 | 60 | 11 |
| 1,000–5,000 | 3 | 3 | 6 |
| 5,000–10,000 | 2 | 1 | 1 |
| 10,000–100,000 | 27 | 4 | 6 |
| ≥100,000 | 91 | 4 | 4 |